JP Morgan Chase’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-34,049
Closed -$923K 5211
2015
Q4
$923K Sell
34,049
-68,211
-67% -$1.76M ﹤0.01% 3157
2015
Q3
$2.24M Buy
102,260
+44,079
+76% +$1.13M ﹤0.01% 2676
2015
Q2
$1.66M Buy
58,181
+1,861
+3% +$54.2K ﹤0.01% 3014
2015
Q1
$1.54M Sell
56,320
-52,336
-48% -$1.44M ﹤0.01% 2997
2014
Q4
$2.87M Sell
108,656
-42,820
-28% -$1.25M ﹤0.01% 2747
2014
Q3
$4.57M Buy
151,476
+39,641
+35% +$1.23M ﹤0.01% 2422
2014
Q2
$3.52M Buy
111,835
+4,377
+4% +$139K ﹤0.01% 2252
2014
Q1
$3.48M Buy
107,458
+17,585
+20% +$616K ﹤0.01% 2287
2013
Q4
$3.27M Buy
89,873
+38,542
+75% +$1.5M ﹤0.01% 2438
2013
Q3
$2M Sell
51,331
-24,806
-33% -$999K ﹤0.01% 2809
2013
Q2
$2.85M Buy
+76,137
New +$3.01M ﹤0.01% 2538

Other funds holding MR

JP Morgan Chase's MR Position: Q1 2016 in Review

JP Morgan Chase sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 34,049 shares — an estimated $923K sold.

JP Morgan Chase first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $4.57M in Q3 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • JP Morgan Chase reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • JP Morgan Chase sold 34,049 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $923K.
  • JP Morgan Chase first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • JP Morgan Chase's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $4.57M in Q3 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on JP Morgan Chase's 13F filing for Q1 2016, filed 10 May 2016.